Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Teva Pharmaceuticals Inc.
Current Parent CompanyTeva Pharmaceutical Industries
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $54,000,000
Year: 2019
Date: December 18, 2019
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Secondary Offense: qui tam whistleblower lawsuit
Mega-ScandalHealthcare Kickbacks
Violation Description: In a qui tam whistleblower case in which there was no government intervention, Teva agreed to pay $54 million to settle allegations that it violated the False Claims Act by using speaker events to provide improper compensation to doctors to induce them to prescribe its products.
Level of Government: federal
Action Type: private litigation
Court: Southern District of New York
Civil or Criminal Case: civil
Case ID: 1:13-cv-03702
Case Name: United States of America, et al., ex. rel. Charles Arnstein and Hossam Senousy v. Teva Pharmaceuticals USA, Inc., et al.
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: Israel
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Link to PACER Case Docket (must be logged in)(click here)
Link to Archived Court Document subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.